Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
02.08.24
/
50%
€140.30
Target price
02.08.25
€200.69
Performance (%)
-22.77%
Price
06.09.24
€108.35
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -22.77%. This prediction currently runs until 02.08.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -5.783% | -5.783% |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $216.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€133.55
02.05.24
02.05.24
€201.87
02.05.25
02.05.25
-18.87%
06.09.24
06.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.95
24.04.24
24.04.24
€187.12
24.04.25
24.04.25
-19.71%
06.09.24
06.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.35
18.03.24
18.03.24
€183.92
18.03.25
18.03.25
-15.58%
06.09.24
06.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
47.73%
03.08.24
03.08.24